B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody

Primary Antibodies

Target: B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C)

Mouse

Human

WB (Predicted): 0.2-2 µg/ml, IHC (Predicted): 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml, FCM: 0.2 µg/ml. Optimal dilutions/concentrations should be determined by the end user.

Monoclonal

Unconjugated

Recombinant

Purified by affinity chromatography.

1 ml

Liquid

FCM

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Shipped within 5-15 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

Q96RJ3

Antibody anti-TNFRSF13C

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.